HIV感染:预防与治疗新进展
本文综述HIV感染的筛查、状态中性照护、暴露前预防、抗逆转录病毒治疗及初级保健中的特殊管理。筛查推荐15至65岁人群;暴露前预防坚持使用可降低99%感染风险;确诊后当日启动整合酶链转移抑制剂方案为标准;40至75岁HIV患者需按动脉粥样硬化性心血管疾病风险评分决定他汀强度。
要点
- 15至65岁人群应筛查HIV,阴性者可选口服或注射暴露前预防,坚持使用降低99%感染风险。
- 确诊HIV后当日启动抗逆转录病毒治疗,初治者首选整合酶链转移抑制剂方案。
- 40至75岁HIV患者按10年动脉粥样硬化性心血管疾病风险评分5%至<20%用中等强度他汀,≥20%用高强度他汀。
核心结论
- HIV仍是重要公共卫生挑战,家庭医生可提供兼顾HIV特殊需求与全人初级保健的综合照护。
研究设计与样本
- 本文为Am Fam Physician发表的综述,汇总HIV预防与治疗的最新证据。
主要发现
- 暴露前预防口服与注射制剂坚持使用可降低99%的HIV感染风险。
- 确诊HIV后当日启动抗逆转录病毒治疗为标准,初治者首选整合酶链转移抑制剂方案。
- 40至75岁HIV患者10年动脉粥样硬化性心血管疾病风险评分5%至<20%应处方中等强度他汀,≥20%应处方高强度他汀。
关键数值与推荐
- 筛查推荐15至65岁人群。
- 暴露前预防适用于HIV阴性患者,坚持使用降低99%感染风险。
- HIV成人除标准年龄适宜疫苗外,应接种甲肝和乙肝疫苗(如无免疫)、脑膜炎球菌疫苗、肺炎球菌疫苗和带状疱疹疫苗。
- HIV患者宫颈癌筛查为终身进行;肛癌筛查男男性行为者和跨性别女性从35岁开始,其他患者从45岁开始。
临床怎么用
- 在初级保健中对15至65岁人群筛查HIV,阴性者评估暴露前预防,确诊者当日启动抗逆转录病毒治疗。
- 对40至75岁HIV患者计算10年动脉粥样硬化性心血管疾病风险评分并据此处方他汀。
- 为HIV成人补充甲肝、乙肝、脑膜炎球菌、肺炎球菌和带状疱疹疫苗,并落实终身宫颈癌筛查及相应肛癌筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HIV remains a significant public health challenge despite highly effective prevention and treatment strategies. Screening for HIV infection is recommended for individuals ages 15 to 65 years. The status neutral approach to care includes preexposure prophylaxis for HIV-negative patients and antiretroviral therapy for patients with HIV. The preexposure prophylaxis options approved by the US Food and Drug Administration include oral and injectable formulations, which reduce HIV acquisition risk by 99% when taken consistently. Same-day antiretroviral therapy initiation is the standard of care for patients diagnosed with HIV infection, with integrase strand transfer inhibitor-based regimens preferred for treatment-naive patients. Key clinical considerations in primary care require modified management approaches for patients with HIV. All patients 40 to 75 years of age with HIV infection and 10-year atherosclerotic cardiovascular disease risk scores between 5% and less than 20% should be prescribed a moderate-intensity statin, and those with risk scores of 20% or greater should receive a high-intensity statin. In addition to standard age-appropriate vaccines, adults with HIV should receive hepatitis A and B (if not immune), meningococcal, pneumococcal, and herpes zoster vaccines. Cancer screening for patients with HIV includes lifelong cervical cancer screening. Anal cancer screening should start at age 35 for men who have sex with men and transgender women, and at age 45 for all other patients. Family physicians are uniquely positioned to deliver comprehensive care that addresses HIV-specific needs and whole person primary care.
引用
- Ganesh PR, Navracruz LC. HIV Infection: What Is New in Prevention and Treatment? Am Fam Physician. 2026. PMID: 42202359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。